Toward Next-Gen Cell Therapy for Pediatric Patients: Neonatal Hepatocytes Tolerate Electroporation-Mediated Gene Editing and Engraft in the Liver
The CRISPR Journal · 2026
DOI: 10.1177/25731599261430830 ↗Kurz gefasst
Fachartikel in der Zeitschrift The CRISPR Journal, 2026. Verfasst von Justin R Gibson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, College of Engineering, Computing, and Applied Sciences, Clemson University, Clemson, South Carolina, USA. Hauptthemen laut MEDLINE: Hepatocytes, Gene Editing, Electroporation, Cell- and Tissue-Based Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Hepatocyte transplantation (HTx) offers a safer, less invasive alternative to orthotopic liver transplantation for inherited metabolic liver diseases, especially in high-risk pediatric patients. Combining HTx with ex vivo gene editing is a promising autologous therapeutic strategy using the patient’s cells. We investigated the feasibility of this approach by applying CRISPR-Cas9 gene knock-out to neonatal mouse hepatocytes and comparing their engraftment potential with that of mature adult cells in the Fah −/− mouse model of hereditary tyrosinemia type I (HT1). Electroporation-mediated gene editing did not significantly impair the ability of neonatal hepatocytes to engraft in vivo . Quantitative histological analysis revealed comparable liver repopulation levels between recipients of gene-edited neonatal cells and adult cells after hepatoxicity-mediated selection, providing a benchmark for electroporation-mediated gene editing in neonatal hepatocytes, and supporting the development of genetically corrected neonatal hepatocyte products as a crucial long-term or bridge-to-transplant therapeutic strategy for pediatric liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, College of Engineering, Computing, and Applied Sciences, Clemson University, Clemson, South Carolina, USA.
- Institute for Human Genetics, Clemson University, Greenwood, South Carolina, USA.
ORCID-Profile: Renee N Cottle
Förderung
- NHLBI NIH HHS
Zitieren
APA
Gibson, J. R., Dhungana, A., Pokhrel, M., Arthur, B. B., Adebayo, O., Hossack, D., & Cottle, R. N. (2026). Toward Next-Gen Cell Therapy for Pediatric Patients: Neonatal Hepatocytes Tolerate Electroporation-Mediated Gene Editing and Engraft in the Liver. The CRISPR Journal. https://doi.org/10.1177/25731599261430830
Vancouver
Gibson JR, Dhungana A, Pokhrel M, Arthur BB, Adebayo O, Hossack D, et al. Toward Next-Gen Cell Therapy for Pediatric Patients: Neonatal Hepatocytes Tolerate Electroporation-Mediated Gene Editing and Engraft in the Liver. The CRISPR Journal. 2026. doi:10.1177/25731599261430830
BibTeX
@article{Gibson2026,
author = {Gibson, Justin R and Dhungana, Abishek and Pokhrel, Menam and Arthur, Benjamin Bessah and Adebayo, Olumide and Hossack, Daniel and Cottle, Renee N},
title = {Toward Next-Gen Cell Therapy for Pediatric Patients: Neonatal Hepatocytes Tolerate Electroporation-Mediated Gene Editing and Engraft in the Liver},
journal = {The CRISPR Journal},
year = {2026},
doi = {10.1177/25731599261430830}
}
EUVIMED